FDA approves cryopreserved formulation of ReNeuron’s retinal stem cell therapy candidate
Notification of Preliminary Results
ReNeuron progresses clinical and regulatory strategy for the US with stroke programme based on positive FDA regulatory feedback
International Society for Cellular Therapy 2017 London Annual Meeting
5th Annual Cell & Gene Investor Day – Boston
7th Annual Advanced Therapies Summit
Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial
Proactive Investors: CFO discusses very significant exosome therapy data
Proactive Investors : CFO ‘very pleased’ to be awarded £1.8m grant
